NoemaLife Group, european leading provider of clinical and hospital software solutions, joins Arab Health 2012 and announces the opening of a NoemaLife subsidiary in Dubai

NoemaLife will join the Arab Health 2012 congress and exhibition, which will be held in Dubai, UAE, at the World Trade and Convention Centre, from 23rd to 26th of January, as a major provider of advanced software solutions for Healthcare. 

Arab Health Exhibition & Congress is the World's largest healthcare congress with 17 CME-accredited conferences and over 500 internationally acclaimed speakers. Now in its 37th year, Arab Health provides an unrivalled platform for the world’s leading manufacturers, wholesalers and distributors to meet the medical and scientific community from the Middle East and beyond: over 3,000 exhibitors from 60 countries; over  71,940 healthcare professionals from across the world; 32 country pavilions.

NoemaLife will be present together with Medasys, number one provider of software for Medical Centre in France, to present a complete and matchless portfolio for all Healthcare organizations including: Hospital Information Systems, Electronic Medical Record, Laboratory Information Systems, Radiology Information Systems & PACS and Infection control software solutions.

NoemaLife’s participation represents a strategic move for the company’s future as the Gulf Cooperation Council (GCC) countries—Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and UAE (the United Arab Emirates) —will face an unparalleled and unprecedented rise in demand for health care over the course of the next two decades. It is estimated that total health-care spending in the region will reach US$60 billion in 2025, up from US$12 billion today. No other region in the world faces such rapid growth in demand with the simultaneous need to realign its health-care systems.

The UAE has emerged as a leading regional commercial hub with state-of-art infrastructure and a world-class business environment. It has now become the logical place to do business in the Middle East and it is the ideal base for multinationals targeting markets in Central Asia, the Middle East, Africa, the Asian Subcontinent and the Eastern Mediterranean. These regions have a population of over 2 billion people and a combined GDP of US$ 6.7 trillion.

NoemaLife has decided to base its Middle East and North African operation in the United Arab Emirates, in Dubai, Dubai Internet City. Daniel Mudaliar has been appointed as Managing Direct and CEO for NoemaLife subsidiary in Dubai. He develops business operations in the Middle East marketplace, including a comprehensive recruitment process for world-class professionals from throughout the region.

Founded in Italy, NoemaLife is an International Group, leading provider of clinical and hospital IT Solutions, dedicated to the enhancement of workflow automation at every level of the care delivering process: departmental, enterprise and regional level. 

NoemaLife already offered over 1.800 high level Healthcare Facilities and 145.000 professionals all over the world a new integrated way to manage and increase effectiveness and efficiency of clinical workflow, based on research and advanced technology.

NoemaLife operates on the international market directly in Italy, France, Germany, United Kingdom, Belgium, Argentina, Japan, United Arab Emirates and can rely on an excellent partners’ network in Latin America, North-Europe and Australia.

To consolidate its growth, NoemaLife went public in May 2006 by listing in the Italian Stock Exchange. In 2011 NoemaLife merged with the French Company Medasys, to become the major player in the healthcare IT industry across Europe.

French company and major healthcare software vendor and integrator of solutions for private and public healthcare organizations, Medasys has based its strategy on an integrated approach for healthcare organizations process management for improving patient care. Its integrated solution covers all the business issues of public and private healthcare organizations in the areas of patient records, production of care, biology and medical imaging in a connected prescription mode, using the most advanced technologies.
Medasys is listed in Compartment C of Euronext Paris (stock MED - ISIN FR)